Publication | Closed Access

Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy

Surgical OncologyUrologyRadiation TherapyMedicineBrachytherapyOncologyRadiation OncologySingle Fraction 19Recurrent Intraprostatic NoduleIntermediate-risk Prostate Cancer